AST
Asterias Biotherapeutics Inc. Series A
AST
AST
Delisted
AST was delisted on the 7th of March, 2019.
64 hedge funds and large institutions have $32.6M invested in Asterias Biotherapeutics Inc. Series A in 2017 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 18 increasing their positions, 12 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
64
Holders Change
-2
Holders Change %
-3.03%
% of All Funds
1.6%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
10
Increased
18
Reduced
12
Closed
11
Calls
$313K
Puts
$439K
Net Calls
-$126K
Net Calls Change
-$229K
Top Buyers
| 1 |
1
BlackRock
New York
|
$4.39M |
| 2 |
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$320K |
| 3 |
3
State Street
Boston,
Massachusetts
|
$1.17M |
| 4 |
4
Northern Trust
Chicago,
Illinois
|
$1.06M |
| 5 |
AWS
5
AJ Wealth Strategies
New York
|
$105K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
MAM
51
Meeder Asset Management
Dublin,
Ohio
| $1K | -$1.87K | -612 | -65% |
|
52
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $1K | -$96 | -16 | -9% |
|
53
Millennium Management
New York
| – | -$79K | -23,222 | Closed |
|
54
Russell Investments Group
London,
United Kingdom
| – | -$75K | -22,144 | Closed |
|
|
WS
55
Wedbush Securities
Los Angeles,
California
| – | -$64K | -18,698 | Closed |
|
|
TC
56
TFS Capital
West Chester,
Pennsylvania
| – | -$56K | -16,381 | Closed |
|
57
Goldman Sachs
New York
| – | -$36K | -10,581 | Closed |
|
|
TRCT
58
Tower Research Capital (TRC)
New York
| – | -$11K | -3,358 | Closed |
|
|
CG
59
Cutler Group
San Francisco,
California
| – | -$10K | -2,984 | Closed |
|